Cite
MLA Citation
Ian E. Krop et al.. “Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.” JCO precision oncology, vol. 6, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150609553.0x000023